BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doumatey AP, Adeyemo A, Zhou J, Lei L, Adebamowo SN, Adebamowo C, Rotimi CN. Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans. Front Cell Infect Microbiol 2020;10:63. [PMID: 32158702 DOI: 10.3389/fcimb.2020.00063] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Brown EL, Essigmann HT, Hoffman KL, Palm NW, Gunter SM, Sederstrom JM, Petrosino JF, Jun G, Aguilar D, Perkison WB, Hanis CL, DuPont HL. Impact of Diabetes on the Gut and Salivary IgA Microbiomes. Infect Immun 2020;88:e00301-20. [PMID: 32900816 DOI: 10.1128/IAI.00301-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Morales-Ferré C, Azagra-Boronat I, Massot-Cladera M, Tims S, Knipping K, Garssen J, Knol J, Franch À, Castell M, Rodríguez-Lagunas MJ, Pérez-Cano FJ. Effects of a Postbiotic and Prebiotic Mixture on Suckling Rats' Microbiota and Immunity. Nutrients 2021;13:2975. [PMID: 34578853 DOI: 10.3390/nu13092975] [Reference Citation Analysis]
3 Zhang Q, Yun Y, An H, Zhao W, Ma T, Wang Z, Yang F. Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality. Front Psychiatry 2021;12:645045. [PMID: 34093266 DOI: 10.3389/fpsyt.2021.645045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 R A, Biswas R, Sasidharan GM, Das S. Uncommon isolation of Desulfovibrio vulgaris from a depressed fracture wound on the forehead. Anaerobe 2020;65:102264. [PMID: 32860932 DOI: 10.1016/j.anaerobe.2020.102264] [Reference Citation Analysis]
5 Arora T, Tremaroli V. Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:761834. [PMID: 34737725 DOI: 10.3389/fendo.2021.761834] [Reference Citation Analysis]
6 Zhang C, Hansen MEB, Tishkoff SA. Advances in integrative African genomics. Trends Genet 2021:S0168-9525(21)00284-5. [PMID: 34740451 DOI: 10.1016/j.tig.2021.09.013] [Reference Citation Analysis]
7 Bakir-Gungor B, Bulut O, Jabeer A, Nalbantoglu OU, Yousef M. Discovering Potential Taxonomic Biomarkers of Type 2 Diabetes From Human Gut Microbiota via Different Feature Selection Methods. Front Microbiol 2021;12:628426. [PMID: 34512559 DOI: 10.3389/fmicb.2021.628426] [Reference Citation Analysis]
8 Sharma R. Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities. Probiotics Antimicrob Proteins 2022. [PMID: 34985682 DOI: 10.1007/s12602-021-09903-3] [Reference Citation Analysis]
9 Li JKM, Wang LL, Wong CYP, Chiu PKF, Teoh JYC, Kwok HSW, Leung SCH, Wong SH, Tsui SKW, Ng CF. A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy. Prostate Cancer Prostatic Dis 2021. [PMID: 33850270 DOI: 10.1038/s41391-021-00360-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Erlandson KM, Liu J, Johnson R, Dillon S, Jankowski CM, Kroehl M, Robertson CE, Frank DN, Tuncil Y, Higgins J, Hamaker B, Wilson CC. An exercise intervention alters stool microbiota and metabolites among older, sedentary adults. Ther Adv Infect Dis 2021;8:20499361211027067. [PMID: 34262758 DOI: 10.1177/20499361211027067] [Reference Citation Analysis]
11 Mehta O, Inbaraj LR, Astbury S, Grove JI, Norman G, Aithal GP, Valdes AM, Vijay A. Gut Microbial Profile Is Associated With Residential Settings and Not Nutritional Status in Adults in Karnataka, India. Front Nutr 2021;8:595756. [PMID: 33708787 DOI: 10.3389/fnut.2021.595756] [Reference Citation Analysis]
12 Bicknell B, Laakso EL, Liebert A, Kiat H. Modifying the Microbiome as a Potential Mechanism of Photobiomodulation: A Case Report. Photobiomodul Photomed Laser Surg 2022;40:88-97. [PMID: 34962422 DOI: 10.1089/photob.2021.0057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Reference Citation Analysis]
14 Raethong N, Nakphaichit M, Suratannon N, Sathitkowitchai W, Weerapakorn W, Keawsompong S, Vongsangnak W. Analysis of Human Gut Microbiome: Taxonomy and Metabolic Functions in Thai Adults. Genes (Basel) 2021;12:331. [PMID: 33668840 DOI: 10.3390/genes12030331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ghorbani Y, Schwenger KJP, Allard JP. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes. Eur J Nutr 2021;60:2361-79. [PMID: 33651137 DOI: 10.1007/s00394-021-02520-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ballan R, Saad SMI. Characteristics of the Gut Microbiota and Potential Effects of Probiotic Supplements in Individuals with Type 2 Diabetes mellitus. Foods 2021;10:2528. [PMID: 34828808 DOI: 10.3390/foods10112528] [Reference Citation Analysis]
17 Yonezawa H, Motegi M, Oishi A, Hojo F, Higashi S, Nozaki E, Oka K, Takahashi M, Osaki T, Kamiya S. Lantibiotics Produced by Oral Inhabitants as a Trigger for Dysbiosis of Human Intestinal Microbiota. Int J Mol Sci 2021;22:3343. [PMID: 33805848 DOI: 10.3390/ijms22073343] [Reference Citation Analysis]
18 Singh H, Miyamoto S, Darshi M, Torralba MG, Kwon K, Sharma K, Pieper R. Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment. Microorganisms 2020;8:E1347. [PMID: 32899353 DOI: 10.3390/microorganisms8091347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tian XY, Xing JW, Zheng QQ, Gao PF. 919 Syrup Alleviates Postpartum Depression by Modulating the Structure and Metabolism of Gut Microbes and Affecting the Function of the Hippocampal GABA/Glutamate System. Front Cell Infect Microbiol 2021;11:694443. [PMID: 34490139 DOI: 10.3389/fcimb.2021.694443] [Reference Citation Analysis]
20 Maskarinec G, Raquinio P, Kristal BS, Setiawan VW, Wilkens LR, Franke AA, Lim U, Le Marchand L, Randolph TW, Lampe JW, Hullar MAJ. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort. PLoS One 2021;16:e0250855. [PMID: 34161346 DOI: 10.1371/journal.pone.0250855] [Reference Citation Analysis]
21 Li YL, Xiao NQ, Tan ZJ. Intestinal microflora in metabolic diseases. Shijie Huaren Xiaohua Zazhi 2020; 28(23): 1192-1199 [DOI: 10.11569/wcjd.v28.i23.1192] [Reference Citation Analysis]
22 Allali I, Abotsi RE, Tow LA, Thabane L, Zar HJ, Mulder NM, Nicol MP. Human microbiota research in Africa: a systematic review reveals gaps and priorities for future research. Microbiome 2021;9:241. [PMID: 34911583 DOI: 10.1186/s40168-021-01195-7] [Reference Citation Analysis]
23 Doden HL, Wolf PG, Gaskins HR, Anantharaman K, Alves JMP, Ridlon JM. Completion of the gut microbial epi-bile acid pathway. Gut Microbes 2021;13:1-20. [PMID: 33938389 DOI: 10.1080/19490976.2021.1907271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yu K, Yu CG, Yin XQ, Wang ZW, Wang XB, Wang LL, Guo S, An YX, Zhao D. Metabolites of gut microbiome are associated with glucose metabolism in non-diabetic obese adults: a Chinese monozygotic twin study. Diabetol Metab Syndr 2021;13:106. [PMID: 34627359 DOI: 10.1186/s13098-021-00724-6] [Reference Citation Analysis]
25 Knudsen JK, Leutscher P, Sørensen S. Gut Microbiota in Bone Health and Diabetes. Curr Osteoporos Rep 2021;19:462-79. [PMID: 33523423 DOI: 10.1007/s11914-020-00629-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Metwaly A, Reitmeier S, Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-022-00581-2] [Reference Citation Analysis]
27 Bui TPN, Mannerås-Holm L, Puschmann R, Wu H, Troise AD, Nijsse B, Boeren S, Bäckhed F, Fiedler D, deVos WM. Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health. Nat Commun 2021;12:4798. [PMID: 34376656 DOI: 10.1038/s41467-021-25081-w] [Reference Citation Analysis]
28 Elbere I, Silamikelis I, Dindune II, Kalnina I, Ustinova M, Zaharenko L, Silamikele L, Rovite V, Gudra D, Konrade I, Sokolovska J, Pirags V, Klovins J. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients. PLoS One 2020;15:e0241338. [PMID: 33125401 DOI: 10.1371/journal.pone.0241338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Oduaran OH, Tamburini FB, Sahibdeen V, Brewster R, Gómez-Olivé FX, Kahn K, Norris SA, Tollman SM, Twine R, Wade AN, Wagner RG, Lombard Z, Bhatt AS, Hazelhurst S. Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition. BMC Microbiol 2020;20:330. [PMID: 33129264 DOI: 10.1186/s12866-020-02017-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Li Y, Liu M, Liu H, Sui X, Liu Y, Wei X, Liu C, Cheng Y, Ye W, Gao B, Wang X, Lu Q, Cheng H, Zhang L, Yuan J, Li M. The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis. Front Cell Infect Microbiol 2021;11:647048. [PMID: 33842393 DOI: 10.3389/fcimb.2021.647048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yu S, Kong L, Gu L, Zhu Y, Liu X, Sang Y, Wang Q, Wang S, Zhang D, Cao H, Tao F, Liu K. Typical antibiotic exposure and dysglycemia risk in an elderly Chinese population. Environ Sci Pollut Res Int 2022. [PMID: 35394631 DOI: 10.1007/s11356-022-20056-w] [Reference Citation Analysis]
32 Kaczmarczyk M, Szulińska M, Łoniewski I, Kręgielska-narożna M, Skonieczna-żydecka K, Kosciolek T, Bezshapkin V, Bogdański P. Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study. Front Cell Infect Microbiol 2022;12:815798. [DOI: 10.3389/fcimb.2022.815798] [Reference Citation Analysis]
33 Niu M, Zhao Y, Xiang L, Jia Y, Yuan J, Dai X, Chen H. 16S rRNA gene sequencing analysis of gut microbiome in a mini-pig diabetes model. Animal Model Exp Med 2022;5:81-8. [PMID: 35213788 DOI: 10.1002/ame2.12202] [Reference Citation Analysis]
34 Zaky A, Glastras SJ, Wong MYW, Pollock CA, Saad S. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease. Int J Mol Sci 2021;22:9641. [PMID: 34502562 DOI: 10.3390/ijms22179641] [Reference Citation Analysis]
35 Garzarella EU, Navajas-Porras B, Pérez-Burillo S, Ullah H, Esposito C, Santarcangelo C, Hinojosa-Nogueira D, Pastoriza S, Zaccaria V, Xiao J, Rufián-Henares JÁ, Daglia M. Evaluating the effects of a standardized polyphenol mixture extracted from poplar-type propolis on healthy and diseased human gut microbiota. Biomed Pharmacother 2022;148:112759. [PMID: 35248845 DOI: 10.1016/j.biopha.2022.112759] [Reference Citation Analysis]
36 Que Y, Cao M, He J, Zhang Q, Chen Q, Yan C, Lin A, Yang L, Wu Z, Zhu D, Chen F, Chen Z, Xiao C, Hou K, Zhang B. Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential. Front Immunol 2021;12:722206. [PMID: 34484230 DOI: 10.3389/fimmu.2021.722206] [Reference Citation Analysis]
37 Koopen AM, Almeida EL, Attaye I, Witjes JJ, Rampanelli E, Majait S, Kemper M, Levels JHM, Schimmel AWM, Herrema H, Scheithauer TPM, Frei W, Dragsted L, Hartmann B, Holst JJ, O'Toole PW, Groen AK, Nieuwdorp M. Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome. Front Microbiol 2021;12:662159. [PMID: 34177842 DOI: 10.3389/fmicb.2021.662159] [Reference Citation Analysis]
38 Huda MN, Kim M, Bennett BJ. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:632335. [PMID: 33897618 DOI: 10.3389/fendo.2021.632335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Balvers M, Deschasaux M, van den Born BJ, Zwinderman K, Nieuwdorp M, Levin E. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area. Nutrients 2021;13:3289. [PMID: 34579166 DOI: 10.3390/nu13093289] [Reference Citation Analysis]